BJDX

BJDX

Bluejay Diagnostics Inc

Net -0.80%top 1%Rev โ€”top 1%1Y
Hold

Bluejay Diagnostics develops medical diagnostics solutions using its Symphony platform, which features an analyzer and single-use protein detection cartridges for measuring key biomarkers in blood, including tests for IL-6, heart conditions, and critical care monitoring.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 1 year ago โ†’$177today

Score Overview

1 Year
Scoreโ€”
Net Growth-0.80%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-85.09%
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency

See the full market ranking โ†’

Bluejay Diagnostics Inc fundamental performance

Across Bluejay Diagnostics Inc's full reported history, from 2021 to 2025, revenue declined from $ 75.00 to $ 0.00 and net income went from -$ 3M to -$ 6M. Revenue increased in 20% of the years measured; net income in 40%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.05โ€”
1 Year2025-08-12
$ 5.92-82.26%
All Time2021-11-10
$ 170.24K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 6M$ 3M
2025$ 0.00-$ 6M$ 5M
2024$ 0.00-$ 7M$ 4M
2023$ 0.00-$ 9M$ 2M
2022$ 249.04K-$ 9M$ 10M
IPO2021$ 75.00-$ 3M$ 19M

Explore beyond BJDX

You're looking at Bluejay Diagnostics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies